Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell Carcinoma

BACKGROUND: The treatment landscape for metastatic clear cell renal cell carcinoma (mRCC) is rapidly changing. It is unknown how adoption of new types of therapies may differ by patient age. OBJECTIVE: To compare trends in first-line therapy use for older (≥70 years) and younger (< 70) patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Osterman, Chelsea K., Deal, Allison M., Milowsky, Matthew I., Bjurlin, Marc A., Rose, Tracy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605347/
https://www.ncbi.nlm.nih.gov/pubmed/33195888
http://dx.doi.org/10.3233/KCA-200089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605347/
https://www.ncbi.nlm.nih.gov/pubmed/33195888
http://dx.doi.org/10.3233/KCA-200089

Ejemplares similares